Goldman Sachs
PROK icon

Goldman Sachs’s ProKidney PROK Stock Holding History

Goldman Sachs’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
203,006
-218,896
-52% -$401K ﹤0.01% 5817
2026
Q1 		$755K Sell
421,902
-259,259
-38% -$550K ﹤0.01% 5297
2025
Q4 		$1.53M Buy
681,161
+516,544
+314% +$1.36M ﹤0.01% 4814
2025
Q3 		$398K Sell
164,617
-416,206
-72% -$1.11M ﹤0.01% 5626
2025
Q2 		$344K Buy
580,823
+362,854
+166% +$283K ﹤0.01% 5369
2025
Q1 		$191K Sell
217,969
-74,027
-25% -$103K ﹤0.01% 5653
2024
Q4 		$493K Buy
291,996
+103,907
+55% +$187K ﹤0.01% 5255
2024
Q3 		$361K Buy
188,089
+143,072
+318% +$325K ﹤0.01% 5218
2024
Q2 		$111K Sell
45,017
-4,247
-9% -$11.4K ﹤0.01% 5390
2024
Q1 		$80.8K Buy
49,264
+11,631
+31% +$17.1K ﹤0.01% 5273
2023
Q4 		$67K Sell
37,633
-12,602
-25% -$27K ﹤0.01% 5349
2023
Q3 		$230K Sell
50,235
-35,721
-42% -$342K ﹤0.01% 4990
2023
Q2 		$962K Buy
85,956
+67,314
+361% +$716K ﹤0.01% 4361
2023
Q1 		$211K Buy
18,642
+2,920
+19% +$31.1K ﹤0.01% 5278
2022
Q4 		$108K Buy
+15,722
New +$150K ﹤0.01% 5463
2022
Q3 		– Sell
-43,400
Closed -$432K – 6473
2022
Q2 		$432K Buy
+43,400
New +$429K ﹤0.01% 5182

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs's PROK Position: Q2 2026 in Review

Goldman Sachs reduced its ProKidney (PROK) stake by 52% in Q2 2026, selling an estimated $401K and leaving 203,006 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #5817.

Goldman Sachs first reported a position in PROK in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.53M in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Goldman Sachs held 203,006 shares of ProKidney worth $414K as of Q2 2026.
  • Goldman Sachs sold 218,896 ProKidney shares in Q2 2026, an estimated $401K.
  • ProKidney made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5817 holding.
  • Goldman Sachs first reported a position in ProKidney in Q2 2022 and has held it in 16 quarters since.
  • Goldman Sachs's ProKidney position peaked at $1.53M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.